Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02040740 · ClinicalTrials.gov registry record

Mediators of Kidney-Bone Communication in Childhood

A clinical trial, sponsored by University of Alabama at Birmingham.

Completed
Registry status
26
Enrollment target

NCT02040740 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 26 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02040740 has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
26 participants
Enrollment target

Study Summary

An identified hormone linking bone and kidney function is Fibroblast Growth Factor-23 (FGF23). Data on the variation of FGF23 levels for bone and mineral metabolism in children are scarce. Currently it is assumed that meeting mineral requirements for the skeleton serves the body's overall needs. However, it is not clear as to whether this is true, particularly with growth. The contribution of dietary factors directly linked with the bone/kidney axis through measurement of intake (via 24hr recall) and kidney nutrient clearance (via serum and urinary analysis) will be included in investigations. Findings will serve as a springboard for delineating more specific mechanisms by which these systems become disordered and are influenced by diet. It is expected that adequacy of nutrients known to have a central role in bone function will optimize the hormonal milieu through crosstalk with the kidney. This effort will allow ongoing investigation in detecting and treating disturbances in mineral metabolism related to kidney disease, specifically in the pediatric population and broaden the understanding of kidney disease itself, as well as that of chronic diseases in which kidney health is of importance, such as diabetes and osteoporosis. Findings of this research may stress the importance of achieving dietary adequacy essential for establishing optimal body composition trajectories, particularly puberty.

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2013-03
Est. Completion 2013-06

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT02040740

The ClinicalTrials.gov registry entry for NCT02040740 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02040740 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02040740 about?

NCT02040740 is a clinical study titled "Mediators of Kidney-Bone Communication in Childhood". An identified hormone linking bone and kidney function is Fibroblast Growth Factor-23 (FGF23). Data on the variation of FGF23 levels for bone and mineral metabolism in children are scarce. Currently it is assumed that meeting mineral requirements for the skeleton serves the body's overall needs. How...

What is the current status of trial NCT02040740?

This trial is currently completed. The enrollment target is 26 participants. The study started on 2013-03. Estimated completion is 2013-06.

Who is sponsoring clinical trial NCT02040740?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.